Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease that affects women
more than men. Several pre-clinical and clinical studies identified 17β-oestradiol (E2), the …

Pulmonary arterial hypertension (PAH) is a complex disease characterized by elevated
pulmonary arterial pressure, pulmonary vascular remodelling and occlusive pulmonary …

Pulmonary arterial hypertension (PAH), a debilitating and incurable disease, predominantly
develops in women. Estradiol metabolism leads to the production of numerous metabolites …

Pulmonary hypertension is a rare disease of the pulmonary vasculature defined as a mean
pulmonary artery pressure> 25 mmHg at rest or 30 mmHg with exercise. Recent therapies …

Pulmonary arterial hypertension (PAH) is a debilitating and progressive disease that
predominantly develops in women. Over the past 15 years, cumulating evidence has …

Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial
hypertension | European Respiratory Society Skip to main content Main menu Home Current …

We thank SP Tofovic and EK Jackson for their interest in our study [ 1]. It is well known that
pulmonary arterial hypertension (PAH) is a female-predominant disease [ 2–4], and this …

The striking female predominance in idiopathic and familial pulmonary arterial hypertension
(PAH) has been well documented since the publication of the National Institutes of Health …

Idiopathic pulmonary arterial hypertension (PAH) is a disabling condition characterized by
PA vasoconstriction and remodeling as well as in situ thrombosis and eventual right heart …

The fact that pulmonary arterial hypertension (PAH) is more common in women than in men
(1) suggests that estrogens importantly contribute to the pathophysiology of PAH (2) …